首页 / 院系成果 / 成果详情页

Interleukin-2 receptor antagonists: Protective factors against new-onset diabetes after renal transplantation 期刊论文

编号：

2cee487f-874a-48f7-9a3e-1ccfd62ea902
作者：

Xue, Mengjuan(薛孟娟)#^[1,2]Zhao, Chenhe^[1];Lv, Chaoyang(吕朝阳)^[1,3]Chen, Minling^[1,4];Xu, Ming(许明)^[5]Rong, Ruiming(戎瑞明)^[5]Zhang, Yao(张尧)^[1,6]Liang, Jing(梁璟)^[1]Gao, Jian^[7];Yu, Mingxiang(于明香)*^[1]Zhu, Tongyu(朱同玉)^[5]Gao, Xin(高鑫)^[1]
语种：

English
期刊：

JOURNAL OF DIABETES ISSN：1753-0393 2018 年 10 卷 11 期 (857 - 865) ; NOV
收录：
关键词：

interleukin-2 kidney transplantation new-onset diabetes after transplantation receptor antagonists
摘要：

Background: The aim of the present study was to examine the association between interleukin-2 receptor antagonists (IL-2Ra) and new-onset diabetes after transplantation (NODAT) among renal transplant recipients (RTRs). Methods: Between January 1993 and March 2014, 915 patients underwent renal transplantation at Zhongshan Hospital. In all, 557 RTRs were included in the present retrospective cohort study. The incidence of NODAT in this cohort was determined and multivariate Cox regression analysis was used to evaluate the risk factors for NODAT and to show the association between IL-2Ra use and NODAT development among RTRs. The cumulative incidence of NODAT was compared between groups treated with or without IL-2Ra. Results: The mean +/- SD postoperative follow-up was 5.08 +/- 3.17 years. The incidence of NODAT at the end of follow-up was 20.3%. After adjusting for potential confounders in the multivariate logistic regression (i.e. age, sex, body mass index, history of smoking, family history of diabetes, duration of dialysis, type of dialysis, donor type, recovery of graft function, acute rejection, hepatitis B or C or cytomegalovirus infection, fasting plasma glucose levels before and 1 week after transplantation, preoperative total cholesterol and triglyceride levels, daily dose of glucocorticoid, immunosuppressive regimen type, and immunosuppressant concentration after transplantation), IL-2Ra use was found to be related to a reduced incidence of NODAT. Conclusions: Use of IL-2Ra is associated with protection against the development of NODAT in RTRs.
推荐引用方式
GB/T 7714：

Xue Mengjuan,Zhao Chenhe,Lv Chaoyang, et al. Interleukin-2 receptor antagonists: Protective factors against new-onset diabetes after renal transplantation [J].JOURNAL OF DIABETES,2018,10(11):857-865.
APA：

Xue Mengjuan,Zhao Chenhe,Lv Chaoyang,Chen Minling,&Gao Xin.(2018).Interleukin-2 receptor antagonists: Protective factors against new-onset diabetes after renal transplantation .JOURNAL OF DIABETES,10(11):857-865.
MLA：

Xue Mengjuan, et al. "Interleukin-2 receptor antagonists: Protective factors against new-onset diabetes after renal transplantation" .JOURNAL OF DIABETES 10,11(2018):857-865.

浏览次数：22  下载次数：0

分享到：

浏览次数：22

下载次数：0

打印次数：0